Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2026-06-15 @ 4:02 PM
Study NCT ID:
NCT06660420
Status:
RECRUITING
Last Update Posted:
2025-10-24
First Post:
2024-10-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
Sponsor:
M.D. Anderson Cancer Center
Organization: